TMO: Improving markets underpin stronger 2027 growth, with AI and reshoring as potential tailwinds

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Markets are strengthening, with pharma and biotech leading the recovery and academic spending expected to improve in 2027. The 2026–2027 organic growth range remains 3%–6%, with a 7% objective for 2028 and AI, reshoring and China as potential tailwinds.

Based on

Disclaimer
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Source: Quartr The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.